Anpario
Website:
Anpario
Index:
Main Market
EPIC: ANP
Supersector:
Health Care
Sector:
Pharmaceuticals and Biotechnology
Subsector:
Biotechnology
Market Cap:
£101.95M
Payout Frequency: Semi-Annual
Anpario Dividend Analysis and Summary
Declared Dividend Terms
- Dividend: 3.60p per share (interim)
- Ex-dividend date: 13/11/2025
- Record date: 14/11/2025
- Payment date: 28/11/2025
- Change vs prior year interim: +11% (H1 2024: 3.25p)
- Dividend cover (H1 2025): ~4.5x by basic EPS (16.34p) and ~4.4x by diluted adjusted EPS (16.01p)
- Estimated cash cost: ~£0.6m (based on ~16.8m shares)
- Liquidity: cash and cash equivalents £11.1m; net cash position; modest lease liabilities
Dividend Sustainability and Growth
- Earnings momentum: H1 revenue +34%, gross margin 51.4% (up 3.9 ppts), adjusted EBITDA +53% to £4.1m, PBT +62% to £3.4m. The 3.60p interim is well covered and supported by improved mix and pricing.
- Cash generation: Net cash from operations of £1.36m despite £1.7m working-capital absorption (inventory rebuild and growth). Cash rose by £0.6m to £11.1m. Coverage of the interim cash outflow is comfortable.
- Capital allocation: Balanced approach—progressive dividend (+11%), small buyback (29k shares, ~£0.1m), modest capex (£0.3m), and integration of Bio-Vet while maintaining net cash. This supports ongoing dividend growth capacity if trading remains robust.
- Payout stance: Interim payout equates to roughly ~21–22% of adjusted EPS, leaving ample reinvestment headroom.
Structural/Policy Factors Affecting Future Dividends
- M&A: Bio-Vet acquisition (completed 30 Sep 2024) performing well; earnout achieved and payable in Q3 2025 (USD 1.0m). Integration under way with a combined US structure and cross-selling. Near-term cash outflow is manageable given cash balances.
- Expansion: New subsidiaries in Colombia and Panama to deepen customer reach; European distribution agreement into feed mill sector. These moves can bolster medium-term earnings resilience and dividend capacity.
- Buyback: Small repurchase programme signals confidence without constraining cash for dividends.
- No change to dividend policy stated; Board cites “continued confidence” and ability to generate cash.
Risks and Flags to Dividend Stability
- Working capital intensity: Inventory rebuild and growth-driven receivables can dampen near-term free cash flow if momentum slows.
- Geographic/commercial concentration: Brazil weakness (tariffs, local competition), credit issues in Egypt, and reliance on large customers (e.g., India integrator) could add volatility.
- Integration execution: Realising Bio-Vet synergies and product registrations (e.g., Credence in US, QuadriCal in new markets) carry timing and regulatory risks.
- Macro/trade risks: Ongoing trade/tariff disputes and sector cyclicality (US swine, dairy) could impact demand and pricing.
Read more
Anpario Annual Dividend Yield - 2.34%
Dividends Used in Calculation:
| Ex-Dividend Date |
Payment Date |
Type |
Amount |
Currency |
| 10/07/2025 |
25/07/2025 |
Final |
8.00p |
GBX |
| 13/11/2025 |
28/11/2025 |
Interim |
3.60p |
GBX |
Total (Annual Dividends Per Share):
11.60p
Dividend Yield =
Annual Dividends Per Share (11.60p)
÷ Share Price (495p)
= 2.34%
Anpario Dividend History
| Ex Dividend Date |
Payment Date |
Type |
Amount |
Currency |
| 13/11/2025 |
28/11/2025 |
Interim |
3.60p |
GBX |
| 10/07/2025 |
25/07/2025 |
Final |
8.00p |
GBX |
| 14/11/2024 |
29/11/2024 |
Interim |
3.25p |
GBX |
| 11/07/2024 |
26/07/2024 |
Final |
7.50p |
GBX |
| 09/11/2023 |
24/11/2023 |
Interim |
3.20p |
GBX |
| 13/07/2023 |
28/07/2023 |
Final |
7.35p |
GBX |
| 10/11/2022 |
25/11/2022 |
Interim |
3.15p |
GBX |
| 14/07/2022 |
29/07/2022 |
Final |
7.00p |
GBX |
| 11/11/2021 |
26/11/2021 |
Interim |
3.00p |
GBX |
| 15/07/2021 |
30/07/2021 |
Final |
6.25p |
GBX |
| 12/11/2020 |
27/11/2020 |
Interim |
2.75p |
GBX |
| 16/07/2020 |
31/07/2020 |
Final |
5.50p |
GBX |
| 14/11/2019 |
29/11/2019 |
Interim |
2.50p |
GBX |
| 11/07/2019 |
26/07/2019 |
Final |
5.00p |
GBX |
| 15/11/2018 |
30/11/2018 |
Interim |
2.20p |
GBX |
| 12/07/2018 |
27/07/2018 |
Final |
4.50p |
GBX |
| 16/11/2017 |
01/12/2017 |
Interim |
2.00p |
GBX |
| 13/07/2017 |
31/07/2017 |
Final |
5.50p |
GBX |
| 14/07/2016 |
29/07/2016 |
Final |
5.00p |
GBX |
| 16/07/2015 |
31/07/2015 |
Final |
4.50p |
GBX |
| 09/07/2014 |
25/07/2014 |
Final |
3.50p |
GBX |
| Year |
Interim |
Final |
Currency |
Total |
Change |
| 2024 |
3.250 |
7.500 |
GBX |
10.750 |
1.890 |
| 2023 |
3.200 |
7.350 |
GBX |
10.550 |
3.940 |
| 2022 |
3.150 |
7.000 |
GBX |
10.150 |
9.720 |
| 2021 |
3.000 |
6.250 |
GBX |
9.250 |
12.120 |
| 2020 |
2.750 |
5.500 |
GBX |
8.250 |
10.000 |
| 2019 |
2.500 |
5.000 |
GBX |
7.500 |
11.940 |
| 2018 |
2.200 |
4.500 |
GBX |
6.700 |
-10.660 |
| 2017 |
2.000 |
5.500 |
GBX |
7.500 |
50.000 |
| 2016 |
|
5.000 |
GBX |
5.000 |
11.110 |
| 2015 |
|
4.500 |
GBX |
4.500 |
28.570 |
| 2014 |
|
3.500 |
GBX |
3.500 |
|
Anpario Dividend Calculator
Anpario Dividend Growth
| Dividend Growth (1Y) |
7.91%
|
| Dividend CAGR (5Y) |
5.21%
|
| Years of Growth |
6
|
| Payout Ratio |
35.55%
|
| Buyback Yield |
-2.99%
|
| Shareholder Yield |
-0.64%
|
| P/E Ratio (TTM) | 16.65 |
| Forward P/E | 14.95 |
| P/FCF | 49.35 |
| Earnings Yield | 5.05% |
| FCF Yield | 2.03% |
| ROE | 13.81% |
| ROCE | 16.48% |
| Profit Margin | 11.71% |
| Operating Margin | 15.67% |
| Gross Margin | 49.01% |